Staff
Dr. Mostafa Samak
Laboratory Animal Science
+49 551 3851-125
B1.13
Kellnerweg 4
37077 Göttingen
-
Microvascular dysfunction in diabetes mellitus
-
Diabetic cardiomyopathy
-
Endothelial biology
Education
-
Ph.D. in Molecular Medicine - Georg-August University of Göttingen
-
Master of Science in Molecular Medicine - Georg-August University of Göttingen
-
Bachelor of Science in Pharmaceutical Sciences - Helwan University - Egypt
- German Centre for Cardiovascular Research
- German Cardiac Society
- European Vascular Biology Organization (EVBO)
-
Samak M et al.: Dysregulation of Krüppel-like factor 2 and myocyte enhancer factor 2D drive cardiac microvascular inflammation in diabetes. Int J Mol Sci. 2023; 24(3):2482. doi: 10.3390/ijms24032482.
-
Samak M et al.: Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes. Biomedicines, 2021 Dec 28; 10(1), 58. doi: 10.3390/biomedicines10010058.
-
Samak M and Hinkel R: Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects. Cells, 2019 Nov 27; 8(12):1530. doi: 10.3390/cells8121530.
-
Samak M et al.: Total Arterial Revascularization: Bypassing Antiquated Notions to Better Alternatives for Coronary Artery Disease. Med Sci Monit Basic Res, 2016 Oct 4; 22:107-114. doi: 10.12659/msmbr.901508.
-
Samak M et al.: Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis. Med Sci Monit Basic Res, 2016 Jul 23; 22:75-79. doi: 10.12659/MSMBR.900437.
-
Samak M et al.: Past and Present of Total Artificial Heart Therapy: A Success Story. Med Sci Monit Basic Res, 2015 Sep 7; 21:183-90. doi: 10.12659/MSMBR.895418.
-
Fatullayev J*, Samak M* et al.: Non-Heart Beating Donor Heart Transplantation: Breaking the Taboo. Med Sci Monit Basic Res, 2015 Jul 15; 21:153-6. doi: 10.12659/MSMBR.894985. *Equal contribution
-
Fatullayev J, Samak M et al.: Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Forseen is a Danger Avoided. Med Sci Monit Basic Res, 2015 Jul 1; 21:141-144. doi: 10.12659/MSMBR.894840.
Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes.
Download (8 MB)